Hopp til hovedinnhold

Lukt- og smaksforstyrrelser

Sist oppdatert: Sist revidert:
Sist revidert av:

  1. Malaty J, Malaty IAC. Smell and taste disorders in primary care. Am Fam Physician 2013; 88: 852-9. American Family Physician  
  2. Landis BN, Stow NW, Lacroix JS, Hugentobler M, Hummel T. Olfactory disorders: the patients' view. Rhinology. 2009;47(4):454–459.
  3. Cetinkaya EA. Coincidence of COVID-19 Infection and Smell-Taste Perception Disorders. J Craniofac Surg. 2020 Sep;31(6):e625-e626. PMID: 32398625. PubMed  
  4. Soter A, Kim J, Jackman A, Tourbier I, Kaul A, Doty RL. Accuracy of self-report in detecting taste dysfunction. Laryngoscope. 2008;118(4):611–617.
  5. Pribitkin E, Rosenthal MD, Cowart BJ. Prevalence and causes of severe taste loss in a chemosensory clinic population. Ann Otol Rhinol Laryngol. 2003;112(11):971–978.
  6. Hummel T, Pfetzing U, Lötsch J. A short olfactory test based on the identification of three odors. J Neurol. 2010;257(8):1316–1321.
  7. Khan AM, Piccirillo J, Kallogjeri D, Piccirillo JF. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2022 Dec 29. Epub ahead of print. PMID: 36580304 PubMed  
  8. Mann NM, Vento JA. A study comparing SPECT and MRI in patients with anosmia after traumatic brain injury. Clin Nucl Med. 2006;31(8):458–462.
  9. Deeb J, Shah M, Muhammed N, et al. A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. QJM. 2010;103(12):941–952.
  10. Steinbach S, Hundt W, Vaitl A, et al. Taste in mild cognitive impairment and Alzheimer's disease. J Neurol. 2010;257(2):238–246.
  11. Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord. 2010;25(11):1646–1651.
  12. Steinbach S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol. 2009;27(11):1899–1905.
  13. Naik BS, Shetty N, Maben EV. Drug-induced taste disorders. Eur J Intern Med. 2010;21(3):240–243.
  14. Jackman AH, Doty RL. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope. 2005;115(12):2209–2212.
  15. Vølstad I, Dahlslett SB, Bachmann-Harildstad G, Steinsvåg S. Endret luktesans -hva kan gjøres?. Tidsskr Nor Legeforen 2022. doi:10.4045/tidsskr.22.0148 DOI  
  16. Sedaghat AR. Chronic Rhinosinusitis. Am Fam Physician. 2017 Oct 15;96(8):500-506. PMID: 29094889. PubMed  
  17. Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database Syst Rev. 2011(7):CD005232. Cochrane (DOI)  
  18. Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M, Hüttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119(3):496–499.
  19. Haehner A, Tosch C, Wolz M, et al. Olfactory training in patients with Parkinson's disease. PLoS One. 2013;8(4):e61680. PubMed  
  20. London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2008;63(2):159–166.
  21. Hummel T, Lötsch J. Prognostic factors of olfactory dysfunction. Arch Otolaryngol Head Neck Surg. 2010;136(4):347–351.
  • Terje Johannessen, professor i allmennmedisin, Trondheim